Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 1.02 is 206% above its 5-year average of -0.96, near the high end of its 5-year range (-3.29–1.02).
395.65% above its 12-month average of -0.34.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.92.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T12:45:41.342Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
1.02
EARNINGS PER SHARE (EPS) AVG TTM
-0.34
EARNINGS PER SHARE (EPS) AVG 3Y
-1.38
EARNINGS PER SHARE (EPS) AVG 5Y
-0.96
EARNINGS PER SHARE (EPS) AVG 10Y
-0.78
EARNINGS PER SHARE (EPS) AVG 15Y
-0.29
EARNINGS PER SHARE (EPS) AVG 20Y
-0.36
CURRENT VS TTM AVG
+395.65%
CURRENT VS 3Y AVG
+173.78%
CURRENT VS 5Y AVG
+205.79%
CURRENT VS 10Y AVG
+231.54%
CURRENT VS 15Y AVG
+450.79%
CURRENT VS 20Y AVG
+383.77%
BioLife Solutions, Inc.
Market Cap
$1.89B
Earnings Per Share (EPS)
1.02
TTM Avg
-0.34
3Y Avg
-1.38
5Y Avg
-0.96
Market Cap
$1.87B
Earnings Per Share (EPS)
-7.01
TTM Avg
2.37
3Y Avg
-1.46
5Y Avg
-2.11
Market Cap
$1.83B
Earnings Per Share (EPS)
0.82
TTM Avg
0.69
3Y Avg
0.92
5Y Avg
1.05
Market Cap
$1.95B
Earnings Per Share (EPS)
-0.80
TTM Avg
-0.89
3Y Avg
-1.03
5Y Avg
-0.96
Market Cap
$1.96B
Earnings Per Share (EPS)
-1.31
TTM Avg
-2.36
3Y Avg
-2.72
5Y Avg
-2.37
Market Cap
$1.97B
Earnings Per Share (EPS)
-2.76
TTM Avg
-2.15
3Y Avg
-1.51
5Y Avg
-0.43
Market Cap
$1.78B
Earnings Per Share (EPS)
N/A
TTM Avg
-3.33
3Y Avg
-3.33
5Y Avg
-3.33
Market Cap
$1.78B
Earnings Per Share (EPS)
-3.36
TTM Avg
-4.53
3Y Avg
-5.16
5Y Avg
-4.47
Market Cap
$2.00B
Earnings Per Share (EPS)
-0.68
TTM Avg
-0.29
3Y Avg
-0.44
5Y Avg
-0.50
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioLife Solutions, Inc. (BLFS) | $1.89B | 1.02 | -0.34 | -1.38 | -0.96 |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.87B | -7.01 | 2.37 | -1.46 | -2.11 |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 0.82 | 0.69 | 0.92 | 1.05 |
| Absci Corporation (ABSI)vs › | $1.95B | -0.80 | -0.89 | -1.03 | -0.96 |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.96B | -1.31 | -2.36 | -2.72 | -2.37 |
| Azenta, Inc. (AZTA)vs › | $1.97B | -2.76 | -2.15 | -1.51 | -0.43 |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | N/A | -3.33 | -3.33 | -3.33 |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | -3.36 | -4.53 | -5.16 | -4.47 |
| AxoGen, Inc. (AXGN)vs › | $2.00B | -0.68 | -0.29 | -0.44 | -0.50 |
| Fortrea Holdings Inc. (FTRE)vs › | $2.01B | -0.93 | -7.24 | -4.12 | -3.06 |
Trailing EPS (TTM)
$1.02
Forward EPS (Est.)
$0.60
P/E Ratio
37.7
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.25 |
| 2024-12-31 | -0.44 |
| 2023-12-31 | -1.55 |
| 2022-12-31 | -3.29 |
| 2021-12-31 | -0.22 |
| 2020-12-31 | -0.03 |
| 2019-12-31 | -0.09 |
| 2018-12-31 | -1.56 |
| 2017-12-31 | -0.21 |
| 2016-12-31 | -0.54 |
| 2015-12-31 | -0.35 |
| 2015-01-31 | -0.31 |
| 2013-12-31 | -0.22 |
| 2012-12-31 | -0.33 |
| 2011-12-31 | -0.39 |
| 2010-12-31 | -0.40 |
| 2009-12-31 | -0.56 |
| 2008-12-31 | -0.56 |
| 2007-12-31 | -0.57 |
| 2006-12-31 | -0.30 |
| 2005-12-31 | -0.70 |
| 2004-12-31 | -0.84 |
| 2003-12-31 | -2.10 |
| 2002-12-31 | 0.28 |
| 2001-12-31 | -4.97 |
| 2000-12-31 | -3.91 |
| 1999-12-31 | -0.49 |
| 1998-12-31 | -0.53 |
| 1997-12-31 | -0.67 |
| 1996-06-30 | -1.82 |
